ActusNews20d
Amoéba announces the publication of the EFSA's final report confirming its positive and definitive conclusions
With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial ...
ActusNews12d
Amoéba announces the initiation of coverage of its stock by Euroland Corporate with a target price of EUR 2.40
With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial ...